SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 72 filers reported holding SERES THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $48,000 | +336.4% | 1,975 | -40.2% | 0.02% | +316.7% |
| Q4 2019 | $11,000 | +450.0% | 3,300 | +1000.0% | 0.01% | +500.0% |
| Q1 2019 | $2,000 | +100.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $2,000 | -33.3% | 300 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $3,000 | +50.0% | 300 | 0.0% | 0.00% | +100.0% |
| Q1 2018 | $2,000 | -33.3% | 300 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $3,000 | -40.0% | 300 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $5,000 | +66.7% | 300 | 0.0% | 0.00% | +50.0% |
| Q2 2017 | $3,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $3,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $3,000 | -25.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $4,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 21,571,764 | $610,696,000 | 16.87% |
| RA Capital Management | 4,750,000 | $134,473,000 | 2.46% |
| ARK Investment Management | 12,293,033 | $348,016,000 | 2.06% |
| Opaleye Management Inc. | 335,312 | $9,493,000 | 1.86% |
| Sio Capital Management, LLC | 316,800 | $8,969,000 | 1.78% |
| Ikarian Capital, LLC | 762,400 | $21,585,000 | 1.56% |
| Nikko Asset Management Americas, Inc. | 5,531,670 | $152,176,000 | 1.35% |
| EAM Global Investors LLC | 121,629 | $3,443,000 | 1.26% |
| EAM Investors, LLC | 133,591 | $3,782,000 | 0.90% |
| GILDER GAGNON HOWE & CO LLC | 3,185,420 | $90,179,000 | 0.56% |